Skip to content

Application of 4C-Based Medication Reconciliation Strategy in Oral Medication Discrepancy Management for Hemodialysis Patients

Application of 4C-Based Medication Reconciliation Strategy in Oral Medication Discrepancy Management for Hemodialysis Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126796
Enrollment
Unknown
Registered
2026-06-16
Start date
2026-06-30
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

require maintenance hemodialysis

Interventions

Intervention group:Oral Medication Reconciliation Strategy Based on the "4C" Model

Sponsors

Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years; 2.Duration of regular hemodialysis >= 3 months; 3.Number of long-term medications >= 1; 4.Provide informed consent and voluntarily participate in this study.

Exclusion criteria

Exclusion criteria: 1. Has a past or current history of psychiatric disorders.; 2. Acute systemic diseases, such as acute inflammation, infectious diseases, and other febrile illnesses; 3.Acute phase of cerebrovascular disease; 4.The investigator considers the participant ineligible for this study.

Design outcomes

Primary

MeasureTime frame
Incidence of medication errors;

Secondary

MeasureTime frame
Chinese version of the Self-Efficacy Scale for Rational Drug Use;Monitor changes in interdialytic blood pressure and laboratory parameters.;

Countries

China

Contacts

Public ContactXue Ruyue

Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine

20579@renji.com+86 21 68383139

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 29, 2026